期刊文献+

真核表达载体pEGFP-C2-miR-126-sponge的构建及其表达活性研究 被引量:6

Construction of pEGFP-C2-miR-126-sponge eukaryotic expression vector and its expression activity
下载PDF
导出
摘要 目的构建靶向miR-126的真核表达载体pEGFP-C2-miR-126-海绵体(sponge),并探讨其下调miR-126的表达对肝癌HepG2细胞体外生长的影响,为后续深入研究miR-126在肝癌发生中的作用提供前期实验基础。方法合成miR-126-sponge,构建pEGFP-C2-miR-126-sponge真核表达载体,体外瞬时转染肝癌细胞HepG2,荧光显微镜下观察EGFP的表达情况;Real-time PCR检测细胞中miR-126的表达水平;MTT法和克隆形成实验检测细胞的增殖变化;划痕实验观察细胞的体外迁移能力改变。结果成功构建pEGFP-C2-miR-126-sponge真核表达载体(命名为p-miR-126-sp);Real-time PCR结果显示,与对照组(p-Cont)相比,p-miR-126-sp组中miR-126表达水平显著降低(P<0.05);MTT检测发现,p-miR-126-sp组中细胞增殖数目明显减少(P<0.05);此外,p-miR-126-sp组的克隆形成数和细胞迁移数均明显减少(P<0.05)。结论 miR-126-sponge可显著下调miR-126的表达水平进而抑制肝癌细胞HepG2的体外增殖及迁移能力。 Objective To construct an eukaryotic expression vector of pEGFP-C2-miR-126-sponge targeting to miR-126 and investigate its effect on the expression of miR-126 and growth of hepatocellular carcinoma cell line HepG2,in order to provide preliminary experimental fundament for study on the role of miR-126 in the pathogenesis of the cancer. Methods The sequence of miR-126-sponge was designed and synthesized. The pEGFP-C2-miR-126-sponge eukaryotic expression vector was constructed and then transiently transfected into HepG2 cells in vitro. The proportion of EGFP-positive cells was observed under the fluorescence microscope. Then,the expression level of miR-126 was detected by real-time PCR. Moreover,the proliferation of HepG2 cells was observed by MTT assay and colony formation assay. Finally,the migration of HepG2 cells was also determined by Scratch assay. Results The pEGFP-C2-miR-126-sponge eukaryotic expression vector( termed as p-miR-126-sp) was successfully constructed. Compared with control group( p-Cont),the expression level of miR-126 was significantly decreased in p-miR-126-sp transfected HepG2 cells( P〈0. 05). MTT assay showed that the proliferation of HepG2 cells was dramatically reduced in p-miR-126-sp transfected cells( P〈0. 05); Furthermore,the number of both colony forming and migrating cells were also remarkably reduced in p-miR-126-sp transfected cells( P〈0. 05). Conclusion The miR-126-sponge can significantly reduce the expression of miR-126 and inhibit the proliferation and migration of the HepG2 cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第1期33-37,共5页 Journal of Third Military Medical University
基金 国家自然科学基金(81260398) 贵州省国际合作项目(10C315)~~
关键词 miR-126-sponge 肝癌 HEPG2细胞 细胞增殖 miR-126-sponge hepatocellular carcinoma HepG2 cells cell proliferation
  • 相关文献

参考文献2

二级参考文献39

  • 1徐林,任涛,周涯,秦安东,郑静.微小RNA-7对人肺癌95D细胞体外增殖的作用[J].肿瘤,2010,30(9):763-767. 被引量:19
  • 2Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 3Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 4Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 5Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 8Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 9Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 10Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.

共引文献987

同被引文献46

  • 1李康,郭强,王翠妮,陈敏,徐薇,熊思东.M1和M2型巨噬细胞表型的比较分析[J].现代免疫学,2008,28(3):177-183. 被引量:61
  • 2胡燕,李永菊,陈超,朱顺飞,郭萌萌,刘思静,郑静,秦娜琳,徐林.microRNA-126基因敲减小鼠的鉴定及其血糖水平变化[J].中南大学学报(医学版),2015,40(1):12-17. 被引量:7
  • 3马振华,马清涌,沙焕臣,王连才,张梅.腹腔巨噬细胞在大鼠重症急性胰腺炎发病机制中的作用[J].西安交通大学学报(医学版),2006,27(6):590-592. 被引量:4
  • 4Shali Chen,Prasanth Puthanveetil,Biao Feng,Scot J. Matkovich,Gerald W. Dorn,Subrata Chakrabarti.Cardiac miR‐133a overexpression prevents early cardiac fibrosis in diabetes[J]. J. Cell. Mol. Med. . 2014 (3)
  • 5Tao Zhang,Chunfang Lv,Liling Li,Sihan Chen,Shenglin Liu,Changyi Wang,Bing Su,Thean Hock Tang.Plasma miR-126 Is a Potential Biomarker for Early Prediction of Type 2 Diabetes Mellitus in Susceptible Individuals[J]. BioMed Research International . 2013
  • 6Faeza Ebrahimi,Vinod Gopalan,Robert Anthony Smith,Alfred King-Yin Lam.miR-126 in human cancers: Clinical roles and current perspectives[J]. Experimental and Molecular Pathology . 2013
  • 7Felix Jansen,Xiaoyan Yang,Marion Hoelscher,Arianna Cattelan,Theresa Schmitz,Sebastian Proebsting,Daniela Wenzel,Sarah Vosen,Bernardo S. Franklin,Bernd K. Fleischmann,Georg Nickenig,Nikos Werner.Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles[J]. Circulation . 2013 (18)
  • 8S. Meng,J.-T. Cao,B. Zhang,Q. Zhou,C.-X. Shen,C.-Q. Wang.Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1[J]. Journal of Molecular and Cellular Cardiology . 2012 (1)
  • 9Anna Zampetaki,Stefan Kiechl,Ignat Drozdov,Peter Willeit,Ursula Mayr,Marianna Prokopi,Agnes Mayr,Siegfried Weger,Friedrich Oberhollenzer,Enzo Bonora,Ajay Shah,Johann Willeit,Manuel Mayr.Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes[J]. Circulation Research . 2010 (6)
  • 10Yoshimasa Saito,Jeffrey M. Friedman,Yoshitomo Chihara,Gerda Egger,Jody C. Chuang,Gangning Liang.Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells[J]. Biochemical and Biophysical Research Communications . 2008 (3)

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部